Paola Mantuano

Ryanodine channel complex stabilizer compound S48168/ARM210 as a disease modifier in dystrophin‐deficient <i>mdx</i> mice: proof‐of‐concept study and independent validation of efficacy

Roberta Francesca Capogrosso, Paola Mantuano, Kitipong Uaesoontrachoon et al. · The FASEB Journal · 2017 · 60 citations · Full text

Medicine, Cell Biology, Neurology +17

Optimize radiochemotherapy in pancreatic cancer: PARP inhibitors a new therapeutic opportunity

Letizia Porcelli, Anna Elisa Quatrale, Paola Mantuano et al. · Molecular Oncology · 2012 · 59 citations · Full text

Medicine, Oncology, Pharmacology +12

Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points

Roberta Francesca Capogrosso, Paola Mantuano, Anna Cozzoli et al. · Journal of Applied Physiology · 2017 · 53 citations · Full text

Life Sciences, Physiology, Biomechanics +16

Effect of a long-term treatment with metformin in dystrophic mdx mice: A reconsideration of its potential clinical interest in Duchenne muscular dystrophy

Paola Mantuano, Francesca Sanarica, Elena Conte et al. · Biochemical Pharmacology · 2018 · 53 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

A long-term treatment with taurine prevents cardiac dysfunction in mdx mice

Antonietta Mele, Paola Mantuano, Michela De Bellis et al. · Translational research · 2018 · 49 citations · Full text

Medicine, Cardiology, Pharmacology +7